08.09.2022 - Milestone Achieved as Immunotherapeutic Agent Under Investigation for the Treatment of Ovarian Cancer Added to Asset PortfolioTAMPA, Fla., Sept. 08, 2022 (GLOBE NEWSWIRE) - H-CYTE, Inc. (OTCQB: HCYT), a medical biosciences company, announced today .
/PRNewswire/ Voltron Therapeutics, Inc., a Lucius Partners portfolio company, today announced that data from the previously announce Study 098 demonstrated.
Will J&J Vaccine Protect Against Delta COVID Variant? Boston Doctors Weigh in msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
Delta COVID Variant: Mass Experts on Its Threat – NECN necn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from necn.com Daily Mail and Mail on Sunday newspapers.